Chabner Colloquium 2016
Program Brochure (PDF)
Abstract Book (PDF)
Session 1:
Epigenetic Mechanisms of Tumor Initiation and Evolution
Bradley E. Bernstein, MD, PhD
Developing Therapies for Transcriptionally Addicted Tumors
Nathanael Gray, PhD
Session 2:
Optimal MAPK Inhibition as a Key Component of Therapeutic Strategies for KRAS Mutant Cancers
Ryan B. Corcoran, MD, PhD
Session 3:
FLT3 Inhibitors in the Therapy of Acute Myeloid Leukemia
Richard M. Stone, MD
Dihydroorotate Dehydrogenase: An Unexpected Metabolic Vulnerability in Acute Myeloid Leukemia
David B. Sykes, MD, PhD
Session 4:
Genomics of a Mitochondria-Rich Tumor
Raj Gopal, MD, PhD
Generation of Models of Human Hematologic Malignancies Using CRISPR Genome Engineering
Zuzana Tothova, MD, PhD
Session 6:
T-Cell Therapy: Current Applications and Future Directions
Marcela V. Maus, MD, PhD
Addressing Cancer Clonal Heterogeneity: Developing Personalized Neoantigen-Based Cancer Vaccines
Catherine J. Wu, MD
Session 7:
Moderator: Aditya Bardia, MD, MPH
Panelists: Darrell Borger, PhD; Leif W. Ellisen, MD, PhD; Justin F. Gainor, MD